Changsha Haike Biotechnology Co., Ltd.

Changsha Haike Biotechnology Co., Ltd. was established in September 2019 and is located in the Lugu Medical Device Industrial Park of Changsha High-tech Development Zone. The company focuses on the field of quantitative allergen detection and diagnosis, and is committed to providing fully quantitative, high-precision allergen in vitro diagnostic instruments and supporting reagent products for the vast number of allergy patients. With the corporate purpose of "Caring for Health, Focusing on Accurate In Vitro Diagnosis; Continuous Innovation, Leading the World's Advanced Level" and the business philosophy of "Innovation, Precision, Quality," it is a professional medical device enterprise integrating new product research and development, manufacturing, and sales. Through the combination of the introduction of international advanced technology and independent research and development, the company has successfully developed a fluorescent magnetic particle immunochemiluminescence instrument platform system and corresponding reagents. The sample volume requirement of this system can be as low as 4µL, the instrument platform is highly automated, and the reagents are prepared with standard extracts, resulting in stronger specificity. Relying on the combination of international technology introduction and cooperation and independent research and development, Changsha Haike Biotechnology will gradually become a leader in the field of allergen and autoimmune disease diagnostic testing in China.